176 related articles for article (PubMed ID: 31635836)
1. The MicroRNA-382-5p/MXD1 Axis Relates to Breast Cancer Progression and Promotes Cell Malignant Phenotypes.
Zhang X; Zhao H; Zhang Y; Yang X; Zhang J; Yi M; Zhang C
J Surg Res; 2020 Feb; 246():442-449. PubMed ID: 31635836
[TBL] [Abstract][Full Text] [Related]
2. miR-382-5p Controls Hematopoietic Stem Cell Differentiation Through the Downregulation of MXD1.
Zini R; Rossi C; Norfo R; Pennucci V; Barbieri G; Ruberti S; Rontauroli S; Salati S; Bianchi E; Manfredini R
Stem Cells Dev; 2016 Oct; 25(19):1433-43. PubMed ID: 27520398
[TBL] [Abstract][Full Text] [Related]
3. MAGI2-AS3 suppresses MYC signaling to inhibit cell proliferation and migration in ovarian cancer through targeting miR-525-5p/MXD1 axis.
Chang H; Zhang X; Li B; Meng X
Cancer Med; 2020 Sep; 9(17):6377-6386. PubMed ID: 32681706
[TBL] [Abstract][Full Text] [Related]
4. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
[TBL] [Abstract][Full Text] [Related]
5. Targeting miR-21 with NL101 blocks c-Myc/Mxd1 loop and inhibits the growth of B cell lymphoma.
Li S; He X; Gan Y; Zhang J; Gao F; Lin L; Qiu X; Yu T; Zhang X; Chen P; Tong J; Qian W; Xu Y
Theranostics; 2021; 11(7):3439-3451. PubMed ID: 33537096
[No Abstract] [Full Text] [Related]
6. MiR-19a/b modulate the metastasis of gastric cancer cells by targeting the tumour suppressor MXD1.
Wu Q; Yang Z; An Y; Hu H; Yin J; Zhang P; Nie Y; Wu K; Shi Y; Fan D
Cell Death Dis; 2014 Mar; 5(3):e1144. PubMed ID: 24675462
[TBL] [Abstract][Full Text] [Related]
7. miR-411-5p inhibits proliferation and metastasis of breast cancer cell via targeting GRB2.
Zhang Y; Xu G; Liu G; Ye Y; Zhang C; Fan C; Wang H; Cai H; Xiao R; Huang Z; Luo Q
Biochem Biophys Res Commun; 2016 Aug; 476(4):607-613. PubMed ID: 27264952
[TBL] [Abstract][Full Text] [Related]
8. Down regulation of miR-202 modulates Mxd1 and Sin3A repressor complexes to induce apoptosis of pancreatic cancer cells.
Farhana L; Dawson MI; Fontana JA
Cancer Biol Ther; 2015; 16(1):115-24. PubMed ID: 25611699
[TBL] [Abstract][Full Text] [Related]
9. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression.
Menbari MN; Rahimi K; Ahmadi A; Elyasi A; Darvishi N; Hosseini V; Mohammadi-Yeganeh S; Abdi M
Life Sci; 2019 Nov; 237():116945. PubMed ID: 31605710
[TBL] [Abstract][Full Text] [Related]
10. miR-424-5p regulates cell proliferation, migration and invasion by targeting doublecortin-like kinase 1 in basal-like breast cancer.
Wang J; Wang S; Zhou J; Qian Q
Biomed Pharmacother; 2018 Jun; 102():147-152. PubMed ID: 29550638
[TBL] [Abstract][Full Text] [Related]
11. miRNA expression in breast cancer varies with lymph node metastasis and other clinicopathologic features.
Wang B; Li J; Sun M; Sun L; Zhang X
IUBMB Life; 2014 May; 66(5):371-7. PubMed ID: 24846313
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-211-5p suppresses tumour cell proliferation, invasion, migration and metastasis in triple-negative breast cancer by directly targeting SETBP1.
Chen LL; Zhang ZJ; Yi ZB; Li JJ
Br J Cancer; 2017 Jun; 117(1):78-88. PubMed ID: 28571042
[TBL] [Abstract][Full Text] [Related]
13. [miRNA-96-5p inhibits the proliferation and migration of gastric cancer cells by targeting FoxQ1].
Yang XY; Li N; Deng WY; Ma YJ; Han XL; Zhang ZY; Xie JL; Luo SX
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):193-199. PubMed ID: 30917455
[No Abstract] [Full Text] [Related]
14. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
[TBL] [Abstract][Full Text] [Related]
15. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
Zhao L; Feng X; Song X; Zhou H; Zhao Y; Cheng L; Jia L
Oncol Rep; 2016 Aug; 36(2):1007-15. PubMed ID: 27375041
[TBL] [Abstract][Full Text] [Related]
16. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.
Wang Y; Yan L; Zhang L; Xu H; Chen T; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
Int J Oncol; 2018 Sep; 53(3):1043-1054. PubMed ID: 30015868
[TBL] [Abstract][Full Text] [Related]
17. Micro-RNA-186-5p inhibition attenuates proliferation, anchorage independent growth and invasion in metastatic prostate cancer cells.
Jones DZ; Schmidt ML; Suman S; Hobbing KR; Barve SS; Gobejishvili L; Brock G; Klinge CM; Rai SN; Park J; Clark GJ; Agarwal R; Kidd LR
BMC Cancer; 2018 Apr; 18(1):421. PubMed ID: 29653561
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-31 controls G protein alpha-13 (GNA13) expression and cell invasion in breast cancer cells.
Rasheed SA; Teo CR; Beillard EJ; Voorhoeve PM; Zhou W; Ghosh S; Casey PJ
Mol Cancer; 2015 Mar; 14():67. PubMed ID: 25889182
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.
Fang C; Wang FB; Li Y; Zeng XT
Biomed Pharmacother; 2016 Dec; 84():1189-1193. PubMed ID: 27788476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
